Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback